Joanna E. Frackowiak

Joanna E. Frackowiak

Auto-generated profile, based on publicly available information

Joanna E. Frackowiak

Laboratory of Experimental and Translational Immunology, Intercollegiate Faculty of Biotechnology of University of Gdansk and Medical University of Gdansk, University of Gdansk, Gdansk, Poland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
AMAnna Mikosik
Anna Mikosik
AJAleksandra Jasiulewicz
Aleksandra Jasiulewicz
ADAgnieszka Daca
Agnieszka Daca
IHIzabella Henc
Izabella Henc
JFJoanna E. Frąckowiak
Joanna E. Frąckowiak
JWJacek M. Witkowski
Jacek M. Witkowski
The immune response is determined by the speed of the T cell reaction to antigens assured by a state of readiness for proliferation and cytokine secretion. Proliferation, apoptosis and motion of many cell types are controlled by cytoplasmic proteases - µ- and m-calpain - and their inhibitor calpastatin, together forming the “calpain-calpastatin system” (CCS), assumed to modify their targets only upon activation-dependent cytoplasmic Ca2+ increase. Contrastingly to this notion, using quantitative real time PCR and semiquantitative flow cytometry respectively, we show here that the CCS genes are constitutively expressed, and that both calpains are constitutively active in resting, circulating human CD4+ and CD8+ lymphocytes. Furthermore, we demonstrate that calpain inhibition in the resting T cells prevents them from proliferation in vitro and greatly reduces secretion of multiple cytokines. The mechanistic reason for these effects of calpain inhibition on T cell functions might be the demonstrated significant reduction of the expression of active (phosphorylated) upstream signalling molecules, including the phospholipase C gamma, p56Lck and NFκB, in the inhibitor-treated cells. Thus, we propose that the constitutive, self-regulatory calpain-calpastatin system activity in resting human T cells is a necessary, controlling element of their readiness for complex and effective response to antigenic challenge.

1 January 2016 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
AKAleksandra Królicka
Aleksandra Królicka
RBRafał Banasiuk
Rafał Banasiuk
JFJoanna E. Frackowiak
Joanna E. Frackowiak
MKMarta Krychowiak-Maśnicka
Marta Krychowiak-Maśnicka
Marta MatuszewskaMarta Matuszewska
Marta Matuszewska
MNMagdalena Narajczyk
Magdalena Narajczyk
A fast, economical, and reproducible method for nanoparticle synthesis has been developed in our laboratory. The reaction is performed in an aqueous environment and utilizes light emitted by commercially available 1 W light-emitting diodes (λ =420 nm) as the catalyst. This method does not require nanoparticle seeds or toxic chemicals. The irradiation process is carried out for a period of up to 10 minutes, significantly reducing the time required for synthesis as well as environmental impact. By modulating various reaction parameters silver nanoparticles were obtained, which were predominantly either spherical or cubic. The produced nanoparticles demonstrated strong antimicrobial activity toward the examined bacterial strains. Additionally, testing the effect of silver nanoparticles on the human keratinocyte cell line and human peripheral blood mononuclear cells revealed that their cytotoxicity may be limited by modulating the employed concentrations of nanoparticles.

8 July 2013 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
AMAnna Mikosik
Anna Mikosik
JFJerzy Foerster
Jerzy Foerster
AJAleksandra Jasiulewicz
Aleksandra Jasiulewicz
JFJoanna Frąckowiak
Joanna Frąckowiak
GCGiuseppina Colonna-Romano
Giuseppina Colonna-Romano
JWJacek M. Witkowski
Jacek M. Witkowski
Background: Ubiquitous system of regulatory, calcium-dependent, cytoplasmic proteases – calpains – and their endogenous inhibitor – calpastatin – is implicated in the proteolytic regulation of activation, proliferation, and apoptosis of many cell types. However, it has not been thoroughly studied in resting and activated human lymphocytes yet, especially in relation to the subjects’ ageing process. The CALPACENT project is an international (Polish-Italian) project aiming at verifying the hypothesis of the role of calpains in the function of peripheral blood immune cells of Polish (Pomeranian) and Italian (Sicilian) centenarians, apparently relatively preserved in comparison to the general elderly population. In this preliminary report we aimed at establishing and comparing the baseline levels of expression of μ- and m-calpain and calpastatin in various, phenotypically defined, populations of human peripheral blood lymphocytes for healthy elderly Sicilians and Poles, as compared to these values observed in young cohort.Results: We have found significant differences in the expression of both μ- and m-calpain as well as calpastatin between various populations of peripheral blood lymphocytes (CD4+, CD8+ and CD19+), both between the age groups compared and within them. Interestingly, significantly higher amounts of μ- and m-calpains but not of calpastatin could be demonstrated in the CD4+CD28- and CD8+CD28-lymphocytes of old subjects (but not in the cells of young individuals), as compared to their CD28+counterparts. Finally, decreased expression of both calpains in the elderly T cells is not related to the accumulation of effector/memory (CD45RO+) cells in the latter, as the expression of both calpains does not differ significantly between the naïve and memory T cells, while is significantly lower for elderly lymphocytes if both populations are taken separately.Conclusions: Observed differences in the amounts of CCS member proteins between various populations of lymphocytes of young and elderly subjects may participate in the impaired proliferative activity of these cells in the elderly.

1 March 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TLTomasz Laskowski
Tomasz Laskowski
MKMichał Kosno
Michał Kosno
WAWitold Andrałojć
Witold Andrałojć
JFJoanna E. Frackowiak
Joanna E. Frackowiak
JBJulia Borzyszkowska-Bukowska
Julia Borzyszkowska-Bukowska
ZMZofia Mazerska
Zofia Mazerska
Members of a novel class of anticancer compounds, exhibiting high antitumor activity, i.e. the unsymmetrical bisacridines (UAs), consist of two heteroaromatic ring systems. One of the ring systems is an imidazoacridinone moiety, with the skeleton identical to the structural base of Symadex. The second one is a 1-nitroacridine moiety, hence it may be regarded as Nitracrine’s structural basis. These monoacridine units are connected by an aminoalkyl linker, which vary in structure. In theory, these unsymmetrical dimers should act as double-stranded DNA (dsDNA) bis-intercalators, since the monomeric units constituting the UAs were previously reported to exhibit an intercalating mode of binding into dsDNA. On the contrary, our earlier, preliminary studies have suggested that specific and/or structurally well-defined binding of UAs into DNA duplexes might not be the case. In this contribution, we have revisited and carefully examined the dsDNA-binding properties of monoacridines C-1305, C-1311 (Symadex), C-283 (Ledakrin/Nitracrine) and C-1748, as well as bisacridines C-2028, C-2041, C-2045 and C-2053 using advanced NMR techniques, aided by molecular modelling calculations and the analysis of UV–VIS spectra, decomposed by chemometric techniques. These studies allowed us to explain, why the properties of UAs are not a simple sum of the features exhibited by the acridine monomers.

20 May 2015 in International Immunology
Verified
Journal Article
Closed access
PDF file
AJAleksandra Jasiulewicz
Aleksandra Jasiulewicz
Katarzyna LisowskaKatarzyna Lisowska
Katarzyna Lisowska
KPKrzysztof Pietruczuk
Krzysztof Pietruczuk
JFJoanna Frąckowiak
Joanna Frąckowiak
TFTamas Fulop
Tamas Fulop
JWJacek M. Witkowski
Jacek M. Witkowski
The mechanisms of maintenance of adequate numbers of B lymphocytes and of protective levels of immunoglobulins in the absence of antigenic (re)stimulation remain not fully understood. Meanwhile, our results presented here show that both peripheral blood naïve and memory B cells can be activated strongly and non-specifically (in a mitogen-like fashion) in 5-day in vitro cultures of anti-CD3- or ConA- stimulated PBMC of healthy people. This polyclonal, bystander activation of the B cells includes multiple divisions of most of them (assessed here by the flow cytometric technique of Dividing Cell Tracking) and significant antibody (IgM and IgG) secretion. Observed proliferation of the CD19+ B cells depends on contact with stimulated Th cells (via CD40 - CD40L interaction) and on the response of B cells to secreted cytokines IL-5, IL-10 and IL-4, and is correlated with the levels of these Th-derived molecules, while it does not involve the ligation of BCR/CD19 complex. We suggest that the effect might reflect the situation occurring in vivo as the homeostatic proliferation of otherwise nonstimulated, peripheral B lymphocytes, providing an always ready pool for efficient antibody production to any new (or cognate) antigen challenge.

28 August 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAnna Mikosik
Anna Mikosik
IHIzabella Henc
Izabella Henc
KRKatarzyna Ruckemann-Dziurdzińska
Katarzyna Ruckemann-Dziurdzińska
JFJoanna E. Frąckowiak
Joanna E. Frąckowiak
APAnna Płoszyńska
Anna Płoszyńska
JWJacek M. Witkowski
Jacek M. Witkowski
Childhood acute lymphoblastic leukemia (ALL) blasts are characterized by inhibited apoptosis promoting fast disease progress. It is known that in chronic lymphocytic and acute myeloid leukemias the reduced apoptosis is strongly related with the activity of calpain-calpastatin system (CCS) composed of cytoplasmic proteases—calpains—performing the modulatory proteolysis of key proteins involved in cell proliferation and apoptosis, and of their endogenous inhibitor—calpastatin. Here, the CCS protein abundance and activity was for the first time studied in childhood ALL blasts and in control bone marrow CD19+ B cells by semi-quantitative flow cytometry and western blotting of calpastatin fragments resulting from endogenous calpain activity. Significantly higher μ-calpain (CAPN1) gene transcription, protein amounts and activity (but not those of m-calpain), with calpastatin amount and transcription of its gene (CAST) greatly varying were observed in CD19+ ALL blasts compared to control cells. Significant inverse relation between the amount/activity of calpain and spontaneous apoptosis was noted. Patients older than 10 years (considered at higher risk) displayed increased amounts and activities of blast calpain. Finally, treatment of blasts with the tripeptide calpain inhibitors II and IV significantly and in dose-dependent fashion increased the percentage of blasts entering apoptosis. Together, these findings make the CCS a potential new predictive tool and therapeutic target in childhood ALL.